The Impact of Pharmaceutical Rebates on Patients’ Drug Expenditures

CMAJ - Canada
doi 10.1503/cmaj.181041
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Joule Inc.

Related search

Measuring the Impact of the Food and Drug Administration (Fda) Unapproved Drug Initiative (Udi) on Drug Prices and Expenditures

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Differential Effects of Two Pharmaceutical Cost Containment Policies on Outpatient Prescription Drug Expenditures in Korea

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

The Impact of the Economic Crisis on Czech Municipal Expenditures

SHS Web of Conferences
2017English

A Projection for Pharmaceutical Expenditures in Japan

Iryo To Shakai
2000English

International Best Practices for Negotiating 'Reimbursement Contracts' With Price Rebates From Pharmaceutical Companies

Health Affairs
MedicineHealth Policy
2013English

The Effectiveness of Maintenance and Its Impact on Capital Expenditures

2003English

Impact of Pharmaceutical Care Interventions on the Quality of Life of Group of Hypertensive Patients

UK Journal of Pharmaceutical Biosciences
2016English

Drug Repurposing in Pharmaceutical Industry and Its Impact on Market Access: Market Access Implications

Journal of Market Access & Health Policy
2014English

Evaluating the Impact of Brexit on the Pharmaceutical Industry

Journal of Pharmaceutical Policy and Practice
ToxicologyPharmaceuticsPharmacologyHealth Policy
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy